New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
Introduction: Botulinum neurotoxins (BoNTs) cause botulism and are the most potent natural toxins known. Immunotherapy with neutralizing monoclonal antibodies (MAbs) is considered to be the most effective immediate response to BoNT exposure. Hybridoma technology remains the preferred method for prod...
Saved in:
Main Authors: | Marina Vladimirovna Silkina, Alena Sergeevna Kartseva, Alena Konstantinovna Riabko, Mariia Aleksandrovna Makarova, Metkhun Madibronovich Rogozin, Yana Olegovna Romanenko, Igor Georgievich Shemyakin, Ivan Alekseevich Dyatlov, Victoria Valerievna Firstova |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2024-07-01
|
Series: | BioImpacts |
Subjects: | |
Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-14-27680.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a Recombinant Fusion Vaccine Candidate Against Lethal <i>Clostridium botulinum</i> Neurotoxin Types A and B
by: Eun-Sun Choi, et al.
Published: (2025-01-01) -
Iatrogenic Botulism After Cosmetic Use of Botulinum Toxin‐A: A Case Series
by: Mohammad Asadi, et al.
Published: (2025-01-01) -
Focal hand dystonia due to hemorrhage of the cervical spinal mass: a case report
by: Pelin Analay, et al.
Published: (2025-01-01) -
Conflicting Clinical Presentation of Infection with Clostridium botulinum and Clostridium perfringens in a 5-Month-Old Infant
by: Barbara Schaub, MD, et al.
Published: (2025-03-01) -
Case Report: Combination of focal vibration therapy and botulinum toxin injections to treat equinus gait in a child with unilateral spastic cerebral palsy
by: Christophe Boulay, et al.
Published: (2025-02-01)